EMA

The European Medicines Agency (EMA) has confirmed that suicidal ideation is a potential side effect of finasteride and urged healthcare professionals to advise patients to stop treatment and seek medical advice if they experience depressed mood, depression, or suicidal thoughts. The advice follows an EU-wide review launched in February of available data on finasteride and dutasteride by the EMA’s Pharmacovigilance Risk Assessment […]